| Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169) |
|---|
| 05/16/2006 | US7045118 Delivery of compounds for the treatment of migraine through an inhalation route |
| 05/16/2006 | US7045116 Treatment of osteomyelitis with radiopharmaceuticals |
| 05/16/2006 | CA2192797C Indolinone compounds for the treatment of disease |
| 05/11/2006 | WO2006050006A2 ((1h-indazol-3-yl)methyl) phenols and (hydroxyphenyl)(1h-indazol-3-yl) methanones as ligands of the estrogen receptor |
| 05/11/2006 | WO2006049978A1 Composition comprising acetaminophen, caffeine and optionally aspirin together with an alkiline agent fr enhanced absorption |
| 05/11/2006 | WO2006049215A1 Combination drug for treating autoimmune disease |
| 05/11/2006 | WO2006048862A2 The use of a protease or a protease inhibitor for the manufacture of medicaments |
| 05/11/2006 | WO2006048430A1 SALTS OF N-ACYL-L-ASPARTATE-β-MONOESTER AND/OR OF N-ACYL-L-GLUTAMATE-Ϝ-MONOESTER, METHOD FOR THE PREPARATION THEREOF AND THEIR USE IN THERAPEUTIC OR COSMETIC COMPOSITIONS |
| 05/11/2006 | WO2006048225A1 Quinuclidine derivatives and their use as muscarinic m3 receptor antagonists |
| 05/11/2006 | WO2006048209A1 Novel bradykinin b1 antagonists, method for producing the same and the use thereof as drugs |
| 05/11/2006 | WO2005106471A3 Diagnostics and therapeutics for diseases associated with c-c chemokine receptor 4 (ccr4) |
| 05/11/2006 | WO2005102390A3 Combinations comprising alpha-2-delta ligands and nmda receptor antagonists |
| 05/11/2006 | WO2005003177A3 Molecules for the targeting and the in situ assembly of therapeutic proteins and use thereof |
| 05/11/2006 | WO2002098351A8 Novel method and composition for inhibition of angiogenesis and tumor growth using compounds based on a sequence within mmp-2 |
| 05/11/2006 | US20060100285 N-hydroxy-4-[2-(4-trifluoromethyl-phenyl)-acetylamino]-benzamide for example; treating infammatory, autoimmune diseases, tumors, and neurodegenerative diseases |
| 05/11/2006 | US20060100246 Synthesis of I kappa B kinase beta inhibitors that are 2-amino-4,6-disubstituted nicotinic acid ester analogs, by reacting an aryl ketone, an aldehyde and a cyanoacetate with an ammonium salt |
| 05/11/2006 | US20060100240 Chemokine receptor binding heterocyclic compounds with enhanced efficacy |
| 05/11/2006 | US20060100227 Pyrimidine derivaties |
| 05/11/2006 | US20060100221 5-[[(2,3-Difluorophenyl)methyl]thio]-7-[[2-hydroxy-1-(hydroxymethyl) 1 methylethyl]amino]-thiazolo[4,5-d]pyrimidin-2(3H)-one; asthma and allergic diseases, autoimmune pathologies such as rheumatoid arthritis and atherosclerosis |
| 05/11/2006 | US20060100211 2-(3,4-dichlorophenylamino)-4-thiocyanato-5-nitro-pyrimidine; 2-chloro-4-(2-acetylamino-ethylamino)-5-trifluoromethyl-pyrimidine; lung cancer |
| 05/11/2006 | US20060100207 Dihydropyridinone derivatives |
| 05/11/2006 | US20060100202 Novel compounds |
| 05/11/2006 | US20060100199 Novel condensed imidazole derivatives |
| 05/11/2006 | US20060100197 7,8,9,10-Tetrahydropyrido[2,3-b]azocine derivatives; CCR5 chemokine receptor antagonists; prophylactic for lymphadenopathy associated and/or human T-cell leukemia/lymphoma virus infections in peripheral mononuclear blood cells; AIDS; quaternization, oxidation, condensation, deprotecting, amidation |
| 05/11/2006 | US20060100166 Compounds for modulating the activity of exchange proteins directly activated by camp (epacs) |
| 05/11/2006 | US20060100152 Methods and compositions in treating pain and painful disorders using 9949, 14230, 760, 62553, 12216, 17719, 41897, 47174, 33408, 10002, 16209, 314, 636, 27410, 33260, 619, 15985, 69112, 2158, 224, 615, 44373, 95431, 22245, 2387, 16658, 55054, 16314, 1613, 1675, 9569 or 13424 molecules |
| 05/11/2006 | US20060100150 Pharmacokinetic and pharmacodynamic modeling of erythropoietin administration |
| 05/11/2006 | US20060100145 Human chondroosteomodulin (tig2), production, and use for the treatment or diagnosis of bone diseases, cartilage diseases, cartilage diseases, obesity, inflammatory diseases, and skin diseases |
| 05/11/2006 | US20060100132 Method for diagnosing inflammatory bowel disease |
| 05/11/2006 | US20060099691 Production of complex carbohydrates |
| 05/11/2006 | US20060099682 Human vanilloid receptors and their uses |
| 05/11/2006 | DE102004054053A1 New 2-(hetero)aryl-imidazoline or tetrahydropyrimidine derivatives, are bradykinin B1 receptor antagonists used e.g. for treating neuropathic or inflammatory pain or migraine |
| 05/11/2006 | CA2589808A1 Combination drug for treating autoimmune disease |
| 05/11/2006 | CA2586033A1 The use of a protease or a protease inhibitor for the manufacture of medicaments |
| 05/11/2006 | CA2585535A1 Novel bradykinin b1 antagonists, method for producing the same and the use thereof as drugs |
| 05/11/2006 | CA2583517A1 Composition comprising acetaminophen, caffeine and optionally aspirin together with an alkaline agent for enhanced absorption |
| 05/11/2006 | CA2583237A1 Quinuclidine derivatives and their use as muscarinic m3 receptor antagonists |
| 05/10/2006 | EP1655305A2 Therapeutic anti-cytomegalovirus compounds |
| 05/10/2006 | EP1655281A1 Salts of N-acyl-L-aspartate-beta-mono-ester and/or of N-acyl-L-glutamate-gamma-monoester, the process for preparing them and their use in therapeutic or cosmetic compositions |
| 05/10/2006 | EP1655026A1 Solid pharmaceutical formulations comprising diacereine and meloxicam |
| 05/10/2006 | EP1655022A1 Remedy or diagnostic for inflammatory disease containing target-directing liposome |
| 05/10/2006 | EP1654262A1 7-azaindole derivatives as cox2 inhibitors |
| 05/10/2006 | EP1654250A1 Substituted pyridones and pyrimidinones with antiinflammatory properties |
| 05/10/2006 | EP1654247A1 Alkynyl aryl carboxamides |
| 05/10/2006 | EP1654237A1 2-aminopyrimidine derivatives |
| 05/10/2006 | EP1654235A1 3- aminocarbonyl, 6-phenyl substituted pyridine-1-oxides as p38 kinase inhibitors |
| 05/10/2006 | EP1654232A1 Sulfonyl substituted n-(biarylmethyl) aminocyclopropanecarboxamides |
| 05/10/2006 | EP1654217A1 2- adamantyl derivatives as p2x7 receptor antagonists. |
| 05/10/2006 | EP1653958A1 Nicotinamide compounds useful as pde4 inhibitors |
| 05/10/2006 | EP1483374B1 Use of l-alpha-lysophosphatidycholine to obtain the differentiation of monocytes in mature dendritric cells in vitro |
| 05/10/2006 | EP1418911B1 2,4,5-trisubstituted thiazolyl derivatives and their antiinflammatory activity |
| 05/10/2006 | EP1294874B1 Cd154 variants and uses thereof |
| 05/10/2006 | EP1255764B1 Purine derivatives |
| 05/10/2006 | EP1194525B1 Combination of lactic acid bacteria and its use for the prevention and/or treatment of infections and inflammatory conditions |
| 05/10/2006 | EP1145001B1 (in vitro) model for gastrointestinal inflammation |
| 05/10/2006 | EP1049700B9 Chemokine receptor antagonists and methods of use therefor |
| 05/10/2006 | CN1771240A 3-phenylfuran-2-one derivatives as cox-2 inhibitor |
| 05/10/2006 | CN1771234A Process for preparing pyrrolotriazine kinase inhibitors |
| 05/10/2006 | CN1771226A 2-propylidene-19-nor-vitamin d compounds |
| 05/10/2006 | CN1771037A Pharmaceutical compositions comprising thieno[2,3-c]pyridine derivatives and use thereof |
| 05/10/2006 | CN1769283A Substituted pyridines and pyridazines with angiogenesis inhibiting activity |
| 05/10/2006 | CN1769282A Substituted pyridines and pyridazines with angiogenesis inhibiting activity |
| 05/10/2006 | CN1768846A Chinese medicinal formulation for activating blood circulation, stopping pain and adjusting chemical balance |
| 05/10/2006 | CN1768832A Medicinal wine for treating injuries and falls, waist and leg pain |
| 05/10/2006 | CN1768820A Dysmenorrhea treating pharmaceutical formulation and preparation method thereof |
| 05/10/2006 | CN1768791A Chinese medicinal formulation for stopping pain for removing Bi |
| 05/10/2006 | CN1768786A Wind-dispelling wine for bone disease |
| 05/10/2006 | CN1768774A Aucklandia root oil containing emulsion, its preparation process and use |
| 05/10/2006 | CN1768759A Nkt cell-activating agents containing alpha-glycosylceramides |
| 05/10/2006 | CN1768751A Method for preparing 'Fen Ma Mei Yu' dispersible tablet |
| 05/10/2006 | CN1768749A Methods and compositions using terfenadine metabolites in combination with leukotriene inhibitors |
| 05/10/2006 | CN1255540C Vaccine-induced hepatitis B viral strain and uses thereof |
| 05/10/2006 | CN1255407C Substituted 3,4-dihydro-pyrido [1,2-a] pyrimidines |
| 05/10/2006 | CN1255406C Substituted 2-acyl-3-(heteroaryl)-imidazo [1,2-a] pyrimidines, and related pharmaceutical compoistions and methods |
| 05/10/2006 | CN1255405C Substituted pyrazoles |
| 05/10/2006 | CN1255401C Aroyl-piperazine derivatives, their preparation and their use as tachykinin antagonists |
| 05/10/2006 | CN1255392C Colchinol derivatives as angiogenesis inhibitors |
| 05/10/2006 | CN1255391C COLCHINOL derivatives as vascular damaging agents |
| 05/10/2006 | CN1255387C Pyrimidine derivatives useful as selective COX-2 inhibitors |
| 05/10/2006 | CN1255172C Medical paste for rheumatism and bone ache |
| 05/10/2006 | CN1255169C Medicine for relaxing muscles and tendons and activating collaterals and dispelling pain |
| 05/10/2006 | CN1255162C Blood nourishing and toxin resolving medicine for treating AIDS |
| 05/10/2006 | CN1255155C Medicine for treating rheumatic and rheumatoid diseases and its preparing method |
| 05/10/2006 | CN1255131C Schefflera (Hantaoye) soft capsule and preparing method thereof |
| 05/10/2006 | CN1255117C Medicinal periplaneta americana extracturm extracting process |
| 05/10/2006 | CN1255103C Diaryl cycloalkyl derivatives, the use thereof as PPAR activators and pharmaceutical compositions containing thereof |
| 05/10/2006 | CN1255100C Soft capsule preparation of Tibet medicine 'unique taste' and preparation method thereof |
| 05/10/2006 | CN1255099C Method for encapsulating active substance |
| 05/09/2006 | US7041796 C3b/C4b Complement Receptor-like molecules and uses thereof |
| 05/09/2006 | US7041786 Guanylate cyclase receptor agonists for the treatment of tissue inflammation and carcinogenesis |
| 05/09/2006 | US7041703 Particularly septic shock and/or autoimmune pathologies in which the aetiopathogenic role of inflammatory cytokines has been ascertained |
| 05/09/2006 | US7041699 Ascorbic compound; L-lysine compound; c) L-proline compound; and d) epigallocatechin gallate, epicatechin gallate, epigallocatechin, epicatechin, or catechin; blocking cancer proliferation and metastasis. |
| 05/09/2006 | US7041696 Induce inflammation, immunology response; autoimmune disease; antiarthritic agents |
| 05/09/2006 | US7041687 Indazole compounds useful as protein kinase inhibitors |
| 05/09/2006 | US7041686 Substituted imidazoles useful in the treatment of inflammatory diseases |
| 05/09/2006 | US7041685 Substituted 3-aryl-5-aryl-[1,2,4]-oxadiazoles and analogs as activators of caspases and inducers of apoptosis and the use thereof |
| 05/09/2006 | US7041682 Antiemetics, antidepressants, anxiolytic agents, antitussive agents |
| 05/09/2006 | US7041680 (R) and (S) isomers of substituted 2-(2,6-dioxopiperidin-3-yl) phthalimides and 1-oxoisoindolines and methods of using the same |
| 05/09/2006 | US7041676 Compounds, compositions, and methods |
| 05/09/2006 | US7041669 1,4-benzofused urea compounds useful in treating cytokine mediated diseases |